Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 05, 2007 08:00 ET | Source: AlphaRx Inc.

AlphaRx Announces Completion of Phase II Clinical Trial for Indaflex

MARKHAM, Ontario, March 5, 2007 (PRIME NEWSWIRE) -- AlphaRx (OTCBB:ALRX) announced today the completion of the treatment phase of the double-blind, placebo & vehicle-controlled, randomized and...
February 20, 2007 08:00 ET | Source: AlphaRx Inc.

AlphaRx's Nanoparticle Formulation of Antituberculosis Drug Shows Promise in Mice Infected With TB (Mycobacterium Tuberculosis)

A leading Chinese TB research institute evaluated the efficacy of the Company's nanoparticle-encapsulated Streptomycin administered 2 times a week versus that of daily nonencapsulated drug...
January 09, 2007 10:45 ET | Source: AlphaRx Inc.

AlphaRx Provides Positive Update On Indaflex

MARKHAM, Ontario, Jan. 9, 2007 (PRIME NEWSWIRE) -- AlphaRx Inc. (OTCBB:ALRX) is pleased to announce that Proprius Pharmaceuticals Inc. has raised up to $17M in a Series A financing. A large portion of...
March 08, 2006 08:00 ET | Source: AlphaRx Inc.

AlphaRx's Joint Venture Company Receives Marketing Approval for Flexogan in Hong Kong

MARKHAM, Ontario, March 8, 2006 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs,...
January 25, 2006 08:00 ET | Source: AlphaRx Inc.

AlphaRx Receives Notice of Allowance for U.S. Patent on Its Drug Delivery Platform

MARKHAM, Ontario, Jan. 25, 2006 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs,...
January 17, 2006 08:00 ET | Source: AlphaRx Inc.

AlphaRx Updates Binoxan Development, a Potential Non-Irritating, Twice-a-Day Eye Drop for Ocular Inflammation

MARKHAM, Ontario, Jan. 17, 2006 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs,...
January 10, 2006 08:00 ET | Source: AlphaRx Inc.

AlphaRx's Joint Venture Company Receives Marketing Approval for Flexogan Ultra in Hong Kong

MARKHAM, Ontario, Jan. 10, 2006 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs,...
April 01, 2004 08:30 ET | Source: AlphaRx Inc.

AlphaRx Launches Flexogan's First National TV Campaign with World Wrestling Entertainment

RICHMOND HILL, Ontario, Canada, April 1, 2004 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX) is launching its first Canadian national TV campaign with World Wrestling Entertainment Canada, Inc. to support...